Press Releases

Cooper University Health Care is now offering Inspire therapy, a surgical therapy for patients with obstructive sleep apnea (OSA) who are unable to tolerate Continuous Positive Airway Pressure (CPAP) therapy.

“Patients with sleep apnea often see us after they trial but fail to tolerate CPAP. Many arrive chronically exhausted, frustrated and looking for surgical options which may improve their quality of life,” said Cooper otolaryngologist Brian Swendseid, MD, who helped bring Inspire therapy to Cooper and has now successfully performed the first implantations within the hospital system. Read more.

Cooper to Build on Its Commitment to Camden and its Residents as It Moves Forward With $3 Billion Expansion

(CAMDEN, NJ) Chairman George E. Norcross III and Cooper University Health Care, South Jersey’s leading academic health system, today announced Cooper will partner with the Eastern Atlantic States Regional Council of Carpenters and its construction manager, Torcon Inc. / P. Agnes Inc., Read more.

(CAMDEN, NJ) – On Friday, August 30, surgical oncologists at MD Anderson Cancer Center at Cooper used histotripsy, an innovative noninvasive technology that uses sound waves to destroy cancerous liver tumors, to treat a patient. This makes MD Anderson at Cooper one of only 20 cancer centers worldwide, and the first in New Jersey and the Philadelphia region, to offer this treatment. Read more.

On this International Overdose Awareness Day, Cooper University Health Care’s Center for Healing joins the global community in raising awareness about overdose, honoring the lives lost, and acknowledging the grief of affected families and friends. Overdoses are preventable, and through education, support, medical treatment, and compassionate care, we can make a significant impact.

The Center for Healing provides innovative, evidence-based, compassionate care for patients with substance use disorders (SUD), complex pain, trauma, and psychiatric disorders on both an inpatient and outpatient basis. Read more.

(CAMDEN, NJ) – Cooper University Health Care’s Center for Healing in conjunction with the Camden Coalition will sponsor a free seminar, Housing First: From the Street to Stability, on Friday, September 13, featuring leading experts sharing best practices in addressing homelessness.

Kaitlan Baston, MD, commissioner of the New Jersey Department of Health, will be the keynote speaker. Other speakers will include Andrew Spiers, LSW, senior program manager with the Corporation for Supportive Housing. Read more.

Sleep Services at Cooper University Hospital Cape Regional has maintained accreditation from the American Academy of Sleep Medicine (AASM) for 15 consecutive years, demonstrating its commitment to the provision of high-quality care for people who have sleep problems.

“Achieving a 15-year accreditation milestone in sleep services is a testament to our commitment to quality and excellence in patient care. This accreditation ensures that our sleep center consistently meets the highest standards of clinical practice, safety, and patient outcomes,” said William R. Read more.

For the fourth consecutive year, Cooper University Health Care was named one of America’s Best-in-State Employers by Forbes, the prominent national business publication. Cooper was one of only 11 health systems in New Jersey to make the Forbes list in 2024.

“It is a tremendous honor for Cooper to be named to Forbes’ prestigious national list for four consecutive years and to be one of only 11 New Jersey health systems recognized as a ‘Best Employer,'” said George E. Read more.

The Cooper Foundation recently received a $50,000 donation from Barbara T. Ferraro Ovarian Cancer Research Foundation, which will support ovarian cancer research at MD Anderson Cancer Center at Cooper. This generous contribution marks the second round of funding within a single year, bringing the total support from the Barbara T. Foundation to $100,000.

The funds will help develop the next generation of innovative ovarian cancer treatments by supporting MD Anderson at Cooper’s critical research into the NRF2 and KEAP1 genes, which play a pivotal role in cancer cell resistance to chemotherapy and immunotherapy. Read more.

(Camden, NJ) – Cardiovascular researchers at Cooper University Health Care have discovered a revolutionary new technology that has the potential to fundamentally change how clinicians study heart and vascular function.

Lawrence Mulligan, PhD, FAHA, director of research in the Department of Anesthesiology at Cooper and Associate Professor at Cooper Medical School of Rowan University, in collaboration with Jeffrey Hill, Sc, ACS, FASE, advanced cardiac sonographer and assistant professor of cardiac ultrasound at Massachusetts College of Pharmacy and Health Sciences University in Worcester, Massachusetts, have developed a patent-pending technology called Myocardial Work Quantification, which has the potential to usher in a new era in cardiovascular research. Read more.

(CAMDEN, NJ) – A team of cardiologists at Cooper and Inspira Cardiac Care recently became the first in the region to implant the EVOQUE tricuspid valve replacement system, the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation. The procedure took place at Cooper University Hospital in Camden.

Tricuspid regurgitation, also known as tricuspid valve regurgitation, is a heart valve disease that occurs when the tricuspid valve doesn’t close properly.  Read more.